Rigvir's new API (Active pharmaceutical ingredient) center of manufacturing has received GMP (Good Manufacturing Practice) compliance certification for the production of Rigvir virus ECHO-7. The project lasted for several years and cost a total of 2.5 million euros.
Contacts for Media Inquiries
Address: Atlasa street 7C, Riga, Latvia, LV-1026
Phone: +371 67 716 132